ES aims to modify the splicing of pre-mRNA dystrophin transcripts converting the severe DMD phenotype into the milder BMD by inducing the production of incomplete but functional dystrophins [15]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.